Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

about

Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

Item

http://www.wikidata.org/entity/Q43072712

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

@en

Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

@nl

type

Item

label

Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

@en

Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

@nl

prefLabel

Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

@en

Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

@nl

P1476

Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

@en

P2093

Bing Huang

http://www.w3.org/2001/XMLSchema#string

Bo Huang

http://www.w3.org/2001/XMLSchema#string

Hong Yu

http://www.w3.org/2001/XMLSchema#string

Hongwei Shao

http://www.w3.org/2001/XMLSchema#string

James J Lin

http://www.w3.org/2001/XMLSchema#string

Jing Yan

http://www.w3.org/2001/XMLSchema#string

Scott J Hallock

http://www.w3.org/2001/XMLSchema#string

Wei Cao

http://www.w3.org/2001/XMLSchema#string

Xiaotao Lin

http://www.w3.org/2001/XMLSchema#string

Xinli Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Fibrinolytic agents for peripheral arterial occlusion

Human plasminogen catalytic domain undergoes an unusual conformational change upon activation

Crystal structure of the catalytic domain of human plasmin complexed with streptokinase

Protein production by auto-induction in high density shaking cultures

Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system

Structural basis of substrate specificity in the serine proteases

The plasminogen (fibrinolytic) system.

Domain interactions between streptokinase and human plasminogen.

Fibrinolysis: an unfinished agenda.

P2888

1477-9560-11-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-9560-11-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235384771

http://www.w3.org/2001/XMLSchema#string

P6179

1036095607

http://www.w3.org/2001/XMLSchema#string

P698

23363549

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis

P932

3724493

http://www.w3.org/2001/XMLSchema#string